Malia R. Bautista

This study evaluates the efficacy of the MAGMAS inhibitor BT9 in medulloblastoma cell lines and mice, showing in vitro antitumor effects but no survival benefit in vivo.

This paper develops an AI-based platform to identify therapeutic targets for opioid use disorder, validates a compound in animal models, and highlights challenges in drug formulation.